Verstovsek, S: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

How We Treat Patients With Polycythemia Vera

Bose, Prithviraj, Verstovsek, Srdan

Journal:

Year:

2017

Language:

english

File:

PDF, 6.10 MB

english, 2017

2

Patient Perceptions in Mast Cell Disorders

Jennings, Susan V., Slee, Valerie M., Zack, Rachel M., Verstovsek, Srdan, George, Tracy I., Shi, Hongliang, Lee, Philina, Castells, Mariana C.

Journal:

Immunology and Allergy Clinics of North America

Year:

2018

Language:

english

File:

PDF, 1.11 MB

english, 2018

3

Updates in the management of polycythemia vera and essential thrombocythemia

Bose, Prithviraj, Verstovsek, Srdan

Journal:

Therapeutic Advances in Hematology

Year:

2019

Language:

english

File:

PDF, 159 KB

english, 2019

4

Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation

M. Jane Ehrke, Srdan Verstovsek, Susan K. Pocchiari, Christian M. Krawczyk, Peter Ujházy, Gintaras Zaleskis, Darbie L. Maccubbin, Jane M. Meer, Enrico Mihich

Journal:

International Journal of Cancer

Year:

1998

Language:

english

File:

PDF, 176 KB

english, 1998

5

Staging of chronic myeloid leukemia in the imatinib era : An Evaluation of the World Health Organization Proposal

Jorge E. Cortes, Moshe Talpaz, Susan O'Brien, Stefan Faderl, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, Mary B. Rios, Jenny Shan, Hagop M. Kantarjian

Journal:

Year:

2006

Language:

english

File:

PDF, 367 KB

english, 2006

6

Spleen deflation and beyond: The pros and cons of Janus kinase 2 inhibitor therapy for patients with myeloproliferative neoplasms

Alfonso Quintás-Cardama, Srdan Verstovsek

Journal:

Year:

2012

Language:

english

File:

PDF, 784 KB

english, 2012

7

Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia

Srdan Verstovsek, Francis J Giles, Susan O’Brien, Stefan Faderl, Hagop M Kantarjian, Michael J Keating, Maher Albitar

Journal:

Leukemia Research

Year:

2004

Language:

english

File:

PDF, 238 KB

english, 2004

8

A potential role of ruxolitinib in leukemia

Naqvi, Kiran, Verstovsek, Srdan, Kantarjian, Hagop, Ravandi, Farhad

Journal:

Expert Opinion on Investigational Drugs

Year:

2011

Language:

english

File:

PDF, 278 KB

english, 2011

9

Chromosome 5q deletion is extremely rare in patients with myelofibrosis

Takahashi, Koichi, Cortes, Jorge, Pierce, Sherry, Abruzzo, Lynne, Kantarjian, Hagop, Verstovsek, Srdan

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 173 KB

english, 2013

10

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms

Yacoub, A., Odenike, O., Verstovsek, S.

Journal:

Current Hematologic Malignancy Reports

Year:

2014

Language:

english

File:

PDF, 361 KB

english, 2014

11

Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer

Liebig, C., Ayala, G., Wilks, J., Verstovsek, G., Liu, H., Agarwal, N., Berger, D. H., Albo, D.

Journal:

Journal of Clinical Oncology

Year:

2009

Language:

english

File:

PDF, 287 KB

english, 2009

12

New Therapeutic Approaches in Polycythemia Vera

Falchi, Lorenzo, Newberry, Kate J., Verstovsek, Srdan

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2015

Language:

english

File:

PDF, 225 KB

english, 2015

13

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

Mascarenhas, J., I. Mughal, T., Verstovsek, S.

Journal:

Current Medicinal Chemistry

Year:

2012

Language:

english

File:

PDF, 321 KB

english, 2012

14

Bone marrow findings in blast phase of polycythemia vera

Hidalgo López, Juliana E., Carballo-Zarate, Adrian, Verstovsek, Srdan, Wang, Sa A., Hu, Shimin, Li, Shaoying, Xu, Jie, Zuo, Wenli, Tang, Zhenya, Yin, C. Cameron, Medeiros, L. Jeffrey, Bueso-Ramos, Car

Journal:

Annals of Hematology

Year:

2017

Language:

english

File:

PDF, 6.70 MB

english, 2017

15

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Barbui, Tiziano, Tefferi, Ayalew, Vannucchi, Alessandro M., Passamonti, Francesco, Silver, Richard T., Hoffman, Ronald, Verstovsek, Srdan, Mesa, Ruben, Kiladjian, Jean-Jacques, Hehlmann, Rȕdiger, Reit

Journal:

Year:

2018

Language:

english

File:

PDF, 586 KB

english, 2018

16

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

Verstovsek, Srdan, Gotlib, Jason, Mesa, Ruben A., Vannucchi, Alessandro M., Kiladjian, Jean-Jacques, Cervantes, Francisco, Harrison, Claire N., Paquette, Ronald, Sun, William, Naim, Ahmad, Langmuir, P

Journal:

Journal of Hematology & Oncology

Year:

2017

Language:

english

File:

PDF, 1.01 MB

english, 2017

17

A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis

Jain, Preetesh, Wang, Sa A., Yin, C. Cameron, Abaza, Yasmin, Verstovsek, Srdan, Estrov, Zeev

Journal:

Year:

2017

Language:

english

File:

PDF, 1.48 MB

english, 2017

18

Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution

Hu, Zhihong, Wang, Wei, Thakral, Beenu, Chen, Zhining, Estrov, Zeev, BuesoâRamos, Carlos E., Verstovsek, Srdan, Medeiros, L Jeffrey, Wang, Sa A.

Journal:

Cytometry Part B: Clinical Cytometry

Year:

2020

File:

PDF, 1.48 MB

2020

19

DIAGNOSTIC PERFORMANCE OF ERYTHROPOIETIN LEVELS IN POLYCYTHEMIA VERA: EXPERIENCE AT A COMPREHENSIVE CANCER CENTER

Davila-Gonzalez, Daniel, Barrios-Ruiz, Alanna, Fountain, Eric, Cheng, Lee, Masarova, Lucia, Verstovsek, Srdan, Rojas-Hernandez, Cristhiam M.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2020

File:

PDF, 1.26 MB

2020

20

Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma–bearing C57BL/6 mice

M. Jane Ehrke, Srdan Verstovšek, Darbie L. Maccubbin, Peter Ujházy, Gintaras Zaleskis, Erica Berleth, Enrico Mihich

Journal:

International Journal of Cancer

Year:

2000

Language:

english

File:

PDF, 177 KB

english, 2000

21

Management of patients with systemic mastocytosis: Review of M. D. Anderson Cancer Center experience

Bryan Hennessy, Francis Giles, Jorge Cortes, Susan O'Brien, Alessandra Ferrajoli, Gladys Ossa, Guillermo Garcia-Manero, Stefan Faderl, Hagop Kantarjian, Srdan Verstovsek

Journal:

American Journal of Hematology

Year:

2004

Language:

english

File:

PDF, 77 KB

english, 2004

22

Granulocytic sarcoma with massive scalp involvement

Alfonso Quintás-Cardama, Antoine J. Harb, Hesham M. Amin, Srdan Verstovsek

Journal:

American Journal of Hematology

Year:

2008

Language:

english

File:

PDF, 234 KB

english, 2008

23

Experience with oral interferon-alpha in patients with essential thrombocythemia and polycythemia vera

Alfonso Quintás-Cardama, Srdan Verstovsek

Journal:

American Journal of Hematology

Year:

2007

Language:

english

File:

PDF, 119 KB

english, 2007

24

Treatment of systemic mastocytosis with denileukin diftitox

Alfonso Quintás-Cardama, Hagop Kantarjian, Srdan Verstovsek

Journal:

American Journal of Hematology

Year:

2007

Language:

english

File:

PDF, 356 KB

english, 2007

25

Treatment of myelofibrosis in younger patients: To transplant or not?

Elias Jabbour, Srdan Verstovsek

Journal:

American Journal of Hematology

Year:

2009

Language:

english

File:

PDF, 55 KB

english, 2009

26

Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia

Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, Susan O'Brien, Stefan Faderl, Moshe Talpaz, Jorge Cortes, Maher Albitar

Journal:

Year:

2002

Language:

english

File:

PDF, 105 KB

english, 2002

27

Neutrophilic-chronic myeloid leukemia : Low levels of p230 BCR/ABL mRNA and undetectable p230 BCR/ABL protein may predict an indolent course

Srdan Verstovsek, Hui Lin, Hagop Kantarjian, Giuseppe Saglio, Daniela De Micheli, Fabrizio Pane, Guillermo Garcia-Manero, Mariano Intrieri, Bruno Rotoli, Francesco Salvatore, Jie Q. Guo, Moshe Talpaz,

Journal:

Year:

2002

Language:

english

File:

PDF, 263 KB

english, 2002

28

In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells

Barbara Scappini, Francesco Onida, Hagop M. Kantarjian, Li Dong, Srdan Verstovsek, Michael J. Keating, Miloslav Beran

Journal:

Year:

2002

Language:

english

File:

PDF, 607 KB

english, 2002

29

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

Alvaro Aguayo, Hagop M. Kantarjian, Elihu H. Estey, Francis J. Giles, Srdan Verstovsek, Taghi Manshouri, Christy Gidel, Susan O'Brien, Michael J. Keating, Maher Albitar

Journal:

Year:

2002

Language:

english

File:

PDF, 95 KB

english, 2002

30

Complete cytogenetic and molecular responses to interferon-α-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis

Hagop M. Kantarjian, Susan O'Brien, Jorge E. Cortes, Jianqin Shan, Francis J. Giles, Mary Beth Rios, Stefan H. Faderl, William G. Wierda, Alessandra Ferrajoli, Srdan Verstovsek, Michael J. Keating, Em

Journal:

Year:

2003

Language:

english

File:

PDF, 122 KB

english, 2003

31

Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia

Srdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, Jorge Cortes, Stefan Faderl, Francis J. Giles, Michael Keating, Maher Albitar

Journal:

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

32

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes

Apostolia Tsimberidou, Elihu Estey, Jorge Cortes, Deborah Thomas, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Michael Keating, Maher Albitar, Susan O'Brien, Hagop Kantarjian, Francis Gil

Journal:

Year:

2003

Language:

english

File:

PDF, 90 KB

english, 2003

33

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage–colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia

Apostolia M. Tsimberidou, Hagop M. Kantarjian, Jorge Cortes, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia-Manero, Srdan Verstovsek, Alessandra Ferrajoli, William Wierda, Yesid Alvarado, Susan M.

Journal:

Year:

2003

Language:

english

File:

PDF, 137 KB

english, 2003

34

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia : Comparison with adult acute myeloid leukemia

Srdan Verstovsek, Taghi Manshouri, Franklin O. Smith, Francis J. Giles, Jorge Cortes, Elihu Estey, Hagop Kantarjian, Michael Keating, Sima Jeha, Maher Albitar

Journal:

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

35

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, Kevin White, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, William Wierda, Steven Kornblau, Jorge Corte

Journal:

Year:

2003

Language:

english

File:

PDF, 76 KB

english, 2003

36

Treatment of Philadelphia chromosome–positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside

Guillermo Garcia-Manero, Moshe Talpaz, Francis J. Giles, Jorge Cortes, Stefan Faderl, Susan O'Brien, Deborah Thomas, Srdan Verstovsek, Mary Beth Rios, Jianquin Shan, Alessandra Ferrajoli, William Wier

Journal:

Year:

2003

Language:

english

File:

PDF, 91 KB

english, 2003

37

Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon-α regimens for early chronic phase

Hagop Kantarjian, Susan O'Brien, Jorges Cortes, Jianqin Shan, Francis Giles, Guillermo Garcia-Manero, Srdan Verstovsek, Stefan Faderl, Mary Beth Rios, Moshe Talpaz

Journal:

Year:

2003

Language:

english

File:

PDF, 106 KB

english, 2003

38

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase : Comparison with historic data

Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Francis J. Giles, Mary Beth Rios, Jianqin Shan, Stefan Faderl, Guillermo Garcia-Manero, Alessandra Ferrajoli, Srdan Verstovsek, William Wierda, Michae

Journal:

Year:

2003

Language:

english

File:

PDF, 95 KB

english, 2003

39

Mammalian target of rapamycin inhibition as therapy for hematologic malignancies

Amit Panwalkar, Srdan Verstovsek, Francis J. Giles

Journal:

Year:

2004

Language:

english

File:

PDF, 588 KB

english, 2004

40

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein

Barbara Scappini, Simona Gatto, Francesco Onida, Clara Ricci, Vladimir Divoky, William G. Wierda, Michael Andreeff, Li Dong, Kimberly Hayes, Srdan Verstovsek, Hagop M. Kantarjian, Miloslav Beran

Journal:

Year:

2004

Language:

english

File:

PDF, 279 KB

english, 2004

41

Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia

Francis J. Giles, Martin S. Tallman, Guillermo Garcia-Manero, Jorge E. Cortes, Deborah A. Thomas, William G. Wierda, Srdan Verstovsek, Marta Hamilton, Emma Barrett, Maher Albitar, Hagop M. Kantarjian

Journal:

Year:

2004

Language:

english

File:

PDF, 130 KB

english, 2004

42

Nuclear factor-KappaB modulation as a therapeutic approach in hematologic malignancies

Amit Panwalkar, Srdan Verstovsek, Francis Giles

Journal:

Year:

2004

Language:

english

File:

PDF, 566 KB

english, 2004

43

New approaches in the treatment of myelofibrosis

Bryan T. Hennessy, Deborah A. Thomas, Francis J. Giles, Hagop Kantarjian, Srdan Verstovsek

Journal:

Year:

2005

Language:

english

File:

PDF, 130 KB

english, 2005

44

Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia—Comparison with historic experience

Hagop Kantarjian, Moshe Talpaz, Susan O'Brien, Francis Giles, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Jianqin Shan, Mary Beth Rios, Richard Champlin, Marcos de Lima, Jorge Cortes

Journal:

Year:

2005

Language:

english

File:

PDF, 291 KB

english, 2005

45

Interferon α therapy for patients with essential thrombocythemia : Final results of a phase II study initiated in 1986

Rashid Saba, Elias Jabbour, Francis Giles, Jorge Cortes, Moshe Talpaz, Susan O'Brien, Emil J. Freireich, Guillermo Garcia-Manero, Hagop Kantarjian, Srdan Verstovsek

Journal:

Year:

2005

Language:

english

File:

PDF, 92 KB

english, 2005

46

Outcome of patients with acute myelogenous leukemia after second salvage therapy

Francis Giles, Susan O'Brien, Jorge Cortes, Srdan Verstovsek, Carlos Bueso-Ramos, Jianqin Shan, Sherry Pierce, Guillermo Garcia-Manero, Michael Keating, Hagop Kantarjian

Journal:

Year:

2005

Language:

english

File:

PDF, 203 KB

english, 2005

47

2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome

Elias Jabbour, Srdan Verstovsek, Francis Giles, Varsha Gandhi, Jorge Cortes, Susan O'Brien, William Plunkett, Guillermo Garcia-Manero, C. Ellen Jackson, Hagop Kantarjian, Michael Andreeff

Journal:

Year:

2005

Language:

english

File:

PDF, 81 KB

english, 2005

48

AMN107, a novel aminopyrimidine inhibitor of p190 Bcr-Abl activation and of in vitro proliferation of Philadelphia-positive acute lymphoblastic leukemia cells

Srdan Verstovsek, Mirna Golemovic, Hagop Kantarjian, Tashi Manshouri, Zeev Estrov, Paul Manley, Tong Sun, Ralph B. Arlinghaus, Leila Alland, Margaret Dugan, Jorge Cortes, Francis Giles, Miloslav Beran

Journal:

Year:

2005

Language:

english

File:

PDF, 224 KB

english, 2005

49

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

Deborah A. Thomas, Stefan Faderl, Susan O'Brien, Carlos Bueso-Ramos, Jorge Cortes, Guillermo Garcia-Manero, Francis J. Giles, Srdan Verstovsek, William G. Wierda, Sherry A. Pierce, Jianqin Shan, Mark

Journal:

Year:

2006

Language:

english

File:

PDF, 170 KB

english, 2006

50

Thalidomide therapy for myelofibrosis with myeloid metaplasia

Deborah A. Thomas, Francis J. Giles, Maher Albitar, Jorge E. Cortes, Srdan Verstovsek, Stefan Faderl, Susan M. O'Brien, Guillermo Garcia-Manero, Michael J. Keating, Sherry Pierce, Jerome Zeldis, Hagop

Journal:

Year:

2006

Language:

english

File:

PDF, 299 KB

english, 2006